Source: China News Network, China News Network, February 24 Comprehensive report, recently, Hans Kluge, director of the World Health Organization's European Regional Office, predicted that the new crown epidemic may end in early 2022. In order to prevent and control the epidemic,

Source: China News Network

China News Network, February 24 Comprehensive report, recently, Hans Kluge, director of the World Health Organization's European Regional Office, predicted that the new crown epidemic may end in early 2022. In order to prevent and control the epidemic, many countries are stepping up the promotion of COVID-19 vaccination. On the 23rd, drugmakers told the US Congress that they plan to significantly increase the delivery of COVID-19 vaccines in the next few weeks.

On February 16, local time, a large-scale vaccination station established at the Oakland Stadium in , California, United States was opened to qualified people. This vaccination station will provide 6,000 doses of vaccine every day. Photo by Liu Guanguan, China News Service reporter

According to reports, Kruger, director of the World Health Organization's European Regional Office, said that the worst situation has passed and people know more about the new coronavirus than when it first began to spread in 2020.

Kruger believes that the new crown epidemic may end in early 2022. The virus will continue to exist among people, but the necessary restrictions will become a thing of the past. However, he stressed that this is just a prediction because no one can say exactly how the situation will develop.

Currently, in order to prevent and control the epidemic, countries have stepped up their efforts to promote COVID-19 vaccination. According to data from the Centers for Disease Control and Prevention (CDC), as of February 23, 82.1 million doses of the new crown vaccine have been delivered across the United States, and about 65 million doses have been injected.

On the same day, at the U.S. House of Representatives COVID-19 vaccine production and delivery hearing, drugmakers also said they plan to significantly increase delivery volume in the next few weeks.

Pfizer and Modena are the only two companies that have obtained the U.S. Food and Drug Administration (FDA) emergency COVID-19 vaccine authorization. Executives of the two companies said they will be able to deliver an additional 130 million doses by the end of March. Under the contract with U.S. federal government , the two companies will provide 600 million doses of vaccines across the United States, and they said they will be delivered by the end of July.

On January 26, local time, at Pennsylvania Railway Station, New York, USA, pedestrians wearing masks exited the station. Photo by Liao Pan, China News Service

John Young, chief business officer of Pfizer, told Representatives that the company has delivered only about 40 million doses of vaccine to the U.S. government so far. But John Young said the company is expected to deliver a total of 120 million doses by the end of March and deliver another 80 million doses by the end of May.

, which has not yet received emergency authorization, said it plans to provide sufficient vaccine doses to more than 20 million Americans by the end of March. Unlike Pfizer and Modena’s vaccines, Johnson & Johnson only needs one dose, so 20 million doses of the vaccine can complete the vaccination of 20 million people.

Richard Nettles, vice president of medical affairs for Janssen's infectious diseases and vaccines division, a subsidiary of Johnson Johnson, said that if the vaccine is authorized by the FDA, 4 million doses will be shipped immediately. The FDA Advisory Committee will hold a meeting on the 26th to review the company's application, and the outside world generally expects that the emergency application will be approved soon.

At the same time, the US Biden government is also increasing the delivery volume to various states. White House Press Spokesperson Shaqi said on February 23 that the total number of vaccines sent to the country every week has now increased to 14.5 million doses, an increase of about 1 million doses from the previous period.